홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Lithium acetate dihydrate → (11S,11aS)-allyl 11-(tert-butyldimethylsilyloxy)-8-hydroxy-7-methoxy-5-oxo-2-((E)-prop-1-enyl)-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate

HRID 513360
인쇄

반응식

HRID 513360 반응식
O.O.C([O-])(=O)C.[Li+].[Si:8]([O:15][C@@H:16]1[N:22]([C:23]([O:25][CH2:26][CH:27]=[CH2:28])=[O:24])[C:21]2[CH:29]=[C:30]([O:35][Si](C(C)C)(C(C)C)C(C)C)[C:31]([O:33][CH3:34])=[CH:32][C:20]=2[C:19](=[O:46])[N:18]2[CH:47]=[C:48](/[CH:50]=[CH:51]/[CH3:52])[CH2:49][C@@H:17]12)([C:11]([CH3:14])([CH3:13])[CH3:12])([CH3:10])[CH3:9]>CN(C=O)C.C(OCC)(=O)C>[Si:8]([O:15][C@@H:16]1[N:22]([C:23]([O:25][CH2:26][CH:27]=[CH2:28])=[O:24])[C:21]2[CH:29]=[C:30]([OH:35])[C:31]([O:33][CH3:34])=[CH:32][C:20]=2[C:19](=[O:46])[N:18]2[CH:47]=[C:48](/[CH:50]=[CH:51]/[CH3:52])[CH2:49][C@@H:17]12)([C:11]([CH3:14])([CH3:13])[CH3:12])([CH3:9])[CH3:10]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 23666338Lithium acetate dihydrateHCID 86717767(11S,11aS)-allyl 11-(tert-butyldimethylsilyloxy)-7-methoxy-5-oxo-2-((E)-prop-1-en yl)-8-(triisopropylsilyloxy)-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10 (5H)-carboxylate

생성물 1

HCID 86717766(11S,11aS)-allyl 11-(tert-butyldimethylsilyloxy)-8-hydroxy-7-methoxy-5-oxo-2-((E)-prop-1-enyl)-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate수율 45%

시약·촉매·용매 2

HCID 6228Dimethylformamide용매
HCID 8857Ethyl Acetate용매

실험 절차

Lithium acetate dihydrate (0.31 g, 3.04 mmol, 1.0 eq) was added to a solution of the diazepine 11 (2.0 g, 3.04 mmol, 1.0 eq) in wet DMF (20 mL) at 25° C. and stirred for 4 hours. The reaction mixture was diluted with ethyl acetate (200 mL) and washed successively with 0.1M citric acid (50 mL, pH 3), water (50 mL) and brine (10 mL), dried over MgSO4, filtered and concentrated under reduced pressure. The residue was purified by flash chromatography (silica gel, 50/50 v/v n-hexane/EtOAc to 25/75 v/v n-hexane/EtOAc) to afford the product as a pale yellow solid (0.68 g, 45%). LC/MS (3.352 min (ES+)), m/z: 501.1 [M+H]+. 1H NMR (400 MHz, CDCl3) δ 7.02 (s, 1H), 6.66 (m, 1H), 6.53 (s, 1H), 6.03 (d, 1H, J=15.5 Hz), 5.80 (s, 1H), 5.63 (d, 1H, J=8.9 Hz), 5.55 (m, 1H), 5.29 (m, 1H), 4.87 (m, 2H), 4.39 (dd, 1H, J=13.5, 4.2 Hz), 4.20 (dd, 1H, J=13.2, 5.7 Hz), 3.73 (s, 3H), 3.59 (m, 1H), 2.81 (dd, 1H, J=16.1, 10.5 Hz), 2.35 (d, 1H, J=15.7 Hz), 1.61 (d, 3H, J=6.4 Hz), 0.67 (s, 9H), 0.05 (s, 3H), 0.00 (s, 3H).

후처리

  1. washwashed successively with 0.1M citric acid (50 mL, pH 3), water (50 mL) and brine (10 mL)
  2. dry with materialdried over MgSO4
  3. filtrationfiltered
  4. concentrationconcentrated under reduced pressure
  5. customThe residue was purified by flash chromatography (silica gel, 50/50 v/v n-hexane/EtOAc to 25/75 v/v n-hexane/EtOAc)

출처 및 근거

ORD 기록
ord-367fa8758ef04307a96af80502673fbd
출처 데이터셋
uspto-grants-2015_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09102704B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트